MedTrace Logo

Evaluating the Clinical Value of Transparent Cap-Assisted Second Examination of the Sigmoid Colon for Improving Colorectal Adenoma Detection Rates

NCT07261319 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 614

Last updated 2025-12-03

No results posted yet for this study

Summary

A prospective, single-center, single-blind, randomized controlled study to evaluate the clinical value of transparent cap-assisted second examination of the sigmoid colon for improving colorectal adenoma detection rates

Conditions

  • Colorectal Adenoma

Interventions

DEVICE

standard second examination of the sigmoid colon

standard second examination of the sigmoid colon

DEVICE

transparent cap-assisted second examination of the sigmoid colon

transparent cap-assisted second examination of the sigmoid colon

Sponsors & Collaborators

  • Fudan University

    lead OTHER

Principal Investigators

  • Danian Ji · Huadong Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2027-12-15
Completion
2027-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07261319 on ClinicalTrials.gov